Twitxy Saved

KlenermanLab

@KlenermanLab

Our research group develops single-molecule methods to address important biological issues, from neurodegenerative disease to how immune responses are triggered
University of Cambridge, UK klenermangroup.co.uk Joined January 2019
84 Following 1.1K Followers 187 Posts

Latest posts 5

KlenermanLab @KlenermanLab
➡️ Read our new paper here: pmc.ncbi.nlm.nih.gov/articles/PMC12…
pmc.ncbi.nlm.nih.gov Lecanemab preferentially binds to smaller aggregates present at early Alzheimer's disease The monoclonal antibodies Aducanumab, Lecanemab, Gantenerumab, and Donanemab were developed for the treatment of Alzheimer's disease (AD). We used single‐molecule detection and super‐resolution...
🧠 Lecanemab prefers to bind to a certain size of toxic protein found in people with early-stage Alzheimer’s, new research by @KlenermanLab & Prof Bart De Strooper reveals.

The study provides vital new insight into how different anti-amyloid drugs work👉buff.ly/E9OrL2G
View quoted post on X
0 replies 1 reposts 6 likes 1.1K views View on X